Thrombosis of a patent foramen ovale closure device: Thrombolytic management

26Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Transcatheter closure of a patent foramen ovale (PFO) offers a valuable alternative to surgery in selected patients with presumed paradoxical embolism. Like for all other devices, several complications have been described. Although the majority of these complications are caused by technical problems of the device itself, thrombosis is a relatively infrequent but feared finding, as it may result in recurrent embolic events and persistent neurological deficits. The majority of the complications after implantation are dealt with by surgical removal of the device and subsequent surgical closure of the PFO. The present case report describes biatrial thrombosis of a PFO device that was successfully treated with thrombolytics and GP IIb/IIIa receptor blockers. In stable patients, this pharmaco-therapeutic approach should be attempted to save the thrombosed PFO device and could therefore offer a valuable alternative to surgical removal of the device. © 2002 Wiley-Liss. Inc.

Cite

CITATION STYLE

APA

Vanderheyden, M., Willaert, W., Claessens, P., Branders, I., Ex, P., & Vermeersch, P. (2002). Thrombosis of a patent foramen ovale closure device: Thrombolytic management. Catheterization and Cardiovascular Interventions, 56(4), 522–526. https://doi.org/10.1002/ccd.10253

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free